How Sex-Specific Immune Cell Responses in Fat Tissue May Explain Obesity Differences
Immune cells in body fat behave differently in males and females, and that difference may help explain why obesity does not affect the sexes the same way. In mouse experiments, UC Riverside scientists found six distinct eosinophil populations in fat tissue — some protective, some inflammatory — and a protein, RELMα, that appears to hold the protective relationship together.
The study, published in PNAS Nexus, was led by University of California, Riverside biomedical scientists Meera Nair and Adam Godzik. It challenges the long-standing assumption that eosinophils — white blood cells best known for allergies and asthma — are largely interchangeable cells with a narrow set of jobs.
- Researchers identified six distinct eosinophil populations in fat tissue, each with its own gene-expression pattern and likely function.
- Female mice carried a protective eosinophil population that communicated more effectively with macrophages; males on a high-fat diet developed more inflammatory populations.
- A macrophage-produced protein, RELMα, appears to stabilize that protective communication — and earlier work showed giving it to mice had protective effects.
- The findings come from mice; whether the same mechanisms operate in human fat tissue remains an open question.
Why study immune cells in fat?
The UCR team used high-resolution single-cell sequencing, a technique that reads gene activity in individual cells, to examine eosinophils in adipose tissue. That is how they found six separate populations rather than one uniform cell type.
What exactly did the study find?
In female mice, one eosinophil population communicated more effectively with macrophages, another immune cell family in fat tissue. According to Nair, that cooperation may help create a healthier environment within fat tissue and support better metabolic function.
Male mice fed a high-fat diet showed the opposite pattern: their fat tissue was more likely to develop eosinophil populations associated with inflammation, and their eosinophils carried gene-activity signatures suggesting weaker protective function.
“Eosinophils are more complex than we once thought,” said Meera Nair, a professor of biomedical sciences in the UCR School of Medicine. “Some populations can protect against obesity, and if we can identify and activate the pathways that produce these protective cells, we may find new ways to improve metabolic health.”
Does cell count matter less than cell type?
The effect of eosinophils on obesity depends not simply on how many are present, but on which populations dominate and how they talk to neighboring cells, the researchers reported.
“This means the relationship between eosinophils and obesity is not simply a matter of how many eosinophils are present,” said Rebecca E. Ruggiero-Ruff, a postdoctoral researcher in Nair’s lab and co-first author of the paper. “Their functional characteristics and how they communicate with other immune cells are also critical.”
Where does RELMα fit in?
The team identified RELMα, a protein produced by macrophages, as a likely stabilizer of the eosinophil–macrophage relationship in female mice. The finding builds on the group’s earlier experiments, which showed that administering RELMα to mice produced protective effects.
Together, the results suggest RELMα may help regulate immune activity within fat tissue and shape how the body responds to obesity — a potential therapeutic lever, though one still far from the clinic.
Could this change how obesity is treated?
The experiments were conducted in mice. Eosinophils have been detected in the fat tissue of people with obesity, but scientists do not yet fully understand what these cells do in the human body, per the study’s authors.
If immune pathways differ between males and females, an immunotherapy for metabolic disease might need different dosing or targets by sex.
“A drug may not activate the same pathways or produce the same effects in males and females, particularly when it targets the immune system,” said co-first author Xinru Qiu, a postdoctoral researcher in Godzik’s lab. “We need to investigate sex-specific biology more thoroughly so that treatments can be optimized for different patients.”
What happens next in the lab?
The team is developing three-dimensional adipose organoids — miniature laboratory models that reproduce features of real fat tissue — to test whether the protective eosinophil behavior seen in mice can be reproduced and studied in human-derived systems. The goal is to determine whether altering immune-cell communication can push human fat tissue toward healthier responses.
“We ultimately hope to develop human adipose organoids that will allow us to investigate whether manipulating immune-cell communication can promote healthier tissue responses,” said Adam Godzik, professor of biomedical sciences and the Bruce D. and Nancy B. Varner Presidential Endowed Chair in Cancer Research at UCR.
Who funded the work?
Funding came from the National Institutes of Health, the UCR School of Medicine, and the California Institute for Regenerative Medicine, according to the study disclosure. The research team also included Lauren Vance, Yuxin He, and Djurdjica Coss. The paper, “Single-cell heterogeneity of adipose eosinophils is shaped by sex and RELMα and linked to macrophage communication networks in obesity,” is published in PNAS Nexus.